Blend Labs (BLND) Financials

$3.50 -0.04 (-0.99%)

Closing price 05/23/2025 03:59 PM Eastern

Extended Trading

$3.56 +0.06 (+1.72%)

As of 05/23/2025 07:21 PM Eastern

Annual Income Statements for Blend Labs

This table shows Blend Labs' income and expenses over time, based on annual financial data. All values are USD millions unless otherwise specified.

Metric	2024	2023	2022	2021	2020	2019
Period end date	12/31/2024	12/31/2023	12/31/2022	12/31/2021	12/31/2020	12/31/2019
Net Income / (Loss) Attributable to Common Shareholders	-60	-185	-769	-171	-75	-81
Consolidated Net Income / (Loss)	-43	-180	-764	-169	-75	-81
Net Income / (Loss) Continuing Operations	-43	-180	-764	-169	-75	-81
Total Pre-Tax Income	-43	-180	-766	-208	-75	-81
Total Operating Income	-50	-156	-746	-197	-75	-82
Total Gross Profit	91	81	90	116	62	31
Total Revenue	162	157	235	234	96	51
Operating Revenue	162	157	235	234	96	51
Total Cost of Revenue	71	76	146	119	34	20
Operating Cost of Revenue	71	76	146	119	34	20
Total Operating Expenses	140	237	836	313	137	113
Selling, General & Admin Expense	51	71	139	129	30	27
Marketing Expense	36	60	85	84	51	38
Research & Development Expense	46	82	138	92	56	49
Amortization Expense	0.00	0.00	8.41	8.14	0.00	-
Impairment Charge	0.00	0.00	450	0.00	0.00	-
Restructuring Charge	7.47	25	15	0.00	0.00	-
Total Other Income / (Expense), net	6.31	-24	-20	-11	0.70	0.28
Interest Expense	6.75	31	25	11	0.00	-
Other Income / (Expense), net	13	7.25	4.92	0.49	0.70	0.28
Income Tax Expense	0.11	0.09	-2.24	-39	0.03	0.01
Preferred Stock Dividends Declared	11	0.00	0.00	1.43	0.00	-
Net Income / (Loss) Attributable to Noncontrolling Interest	6.19	5.44	4.80	0.77	0.00	-
Basic Earnings per Share	($0.24)	($0.76)	($3.28)	($1.30)	($1.89)	($2.49)
Weighted Average Basic Shares Outstanding	253.92M	245.21M	234.16M	131.99M	39.41M	32.78M
Diluted Earnings per Share	($0.24)	($0.76)	($3.28)	($1.30)	($1.89)	($2.49)
Weighted Average Diluted Shares Outstanding	253.92M	245.21M	234.16M	131.99M	39.41M	32.78M
Weighted Average Basic & Diluted Shares Outstanding	259.66M	252.05M	242.85M	232.41M	-	-

This table shows Blend Labs' income and expenses over time, based on quarterly financial data. All values are USD millions unless otherwise specified.

Metric	Q1 2025	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022
Period end date	3/31/2025	12/31/2024	9/30/2024	6/30/2024	3/31/2024	12/31/2023	9/30/2023	6/30/2023	3/31/2023	12/31/2022	9/30/2022
Net Income / (Loss) Attributable to Common Shareholders	-15	-6.51	-8.25	-24	-22	-32	-43	-43	-67	-83	-134
Consolidated Net Income / (Loss)	-9.41	-0.71	-2.63	-19	-21	-30	-42	-41	-66	-81	-133
Net Income / (Loss) Continuing Operations	-6.61	-0.71	-2.63	-19	-21	-30	-42	-41	-66	-81	-133
Total Pre-Tax Income	-6.58	-0.68	-2.61	-19	-21	-30	-42	-41	-66	-81	-133
Total Operating Income	-7.69	-1.79	-13	-13	-21	-22	-36	-37	-61	-75	-130
Total Gross Profit	19	25	26	22	18	20	22	23	16	14	21
Total Revenue	27	41	45	40	35	36	41	43	37	43	55
Operating Revenue	27	41	45	40	35	36	41	43	37	43	55
Total Cost of Revenue	7.81	17	19	19	17	16	19	19	21	28	34
Operating Cost of Revenue	7.81	17	19	19	17	16	19	19	21	28	34
Total Operating Expenses	27	27	39	35	39	42	58	60	77	90	151
Selling, General & Admin Expense	11	11	13	13	14	15	16	20	21	33	32
Marketing Expense	7.19	6.58	9.88	9.37	10	12	14	16	18	20	21
Research & Development Expense	7.52	8.86	10	13	14	14	19	22	26	33	34
Restructuring Charge	0.72	0.12	6.17	0.21	0.98	0.69	9.12	2.35	13	2.96	5.94
Total Other Income / (Expense), net	1.11	1.11	11	-6.06	0.55	-8.58	-5.58	-4.72	-4.69	-5.81	-2.88
Interest Expense	0.00	-	0.00	1.65	5.10	7.09	8.21	7.95	7.57	7.35	6.16
Other Income / (Expense), net	1.11	1.11	11	-4.41	5.65	-1.50	2.63	3.23	2.88	1.54	3.28
Income Tax Expense	0.03	0.03	0.02	0.02	0.04	-0.07	0.04	0.05	0.07	0.48	0.01
Net Income / (Loss) Discontinued Operations	-2.80	-	-	-	-	-	-	-	-	-	-
Preferred Stock Dividends Declared	4.20	2.71	4.05	2.66	1.46	-2.06	0.00	0.00	2.06	-46	7.85
Net Income / (Loss) Attributable to Noncontrolling Interest	1.07	3.09	1.58	1.51	0.01	3.49	1.39	1.33	-0.78	48	-6.62
Weighted Average Basic Shares Outstanding	258.83M	253.92M	254.91M	253.07M	250.93M	245.21M	246.41M	244.26M	241.44M	234.16M	235.27M
Weighted Average Diluted Shares Outstanding	258.83M	253.92M	254.91M	253.07M	250.93M	245.21M	246.41M	244.26M	241.44M	234.16M	235.27M
Weighted Average Basic & Diluted Shares Outstanding	258.52M	259.66M	255.93M	254.24M	252.38M	252.05M	248.20M	245.89M	243.85M	242.85M	237.70M

This table details how cash moves in and out of Blend Labs' business through operations, investing, and financing, using annual figures. All values are USD millions unless otherwise specified.

Metric	2024	2023	2022	2021	2020	2019
Period end date	12/31/2024	12/31/2023	12/31/2022	12/31/2021	12/31/2020	12/31/2019
Net Change in Cash & Equivalents	11	-91	-89	172	18	8.21
Net Cash From Operating Activities	-13	-128	-190	-128	-65	-59
Net Cash From Continuing Operating Activities	-13	-128	-190	-128	-65	-59
Net Income / (Loss) Continuing Operations	-43	-180	-764	-169	-75	-81
Consolidated Net Income / (Loss)	-43	-180	-764	-169	-75	-81
Depreciation Expense	2.29	2.46	11	11	3.99	4.76
Amortization Expense	7.28	9.24	11	9.63	6.00	2.27
Non-Cash Adjustments To Reconcile Net Income	19	45	559	74	11	11
Changes in Operating Assets and Liabilities, net	1.89	-4.25	-7.35	-52	-11	4.06
Net Cash From Investing Activities	45	127	99	-634	-7.92	-66
Net Cash From Continuing Investing Activities	45	127	99	-634	-7.92	-66
Purchase of Property, Plant & Equipment	-9.84	-0.59	-2.07	-1.89	-1.32	-0.58
Purchase of Investments	-102	-236	-146	-352	-174	-151
Divestitures	9.08	0.00	0.00	-	-	-
Sale and/or Maturity of Investments	153	366	247	125	167	86
Other Investing Activities, net	-5.28	-2.50	0.00	-3.00	0.00	0.00
Net Cash From Financing Activities	-21	-91	2.22	934	91	133
Net Cash From Continuing Financing Activities	-21	-91	2.22	934	91	133
Repayment of Debt	-145	-85	0.00	2.88	0.00	-0.07
Repurchase of Common Equity	-9.48	0.00	0.00	-	-	-0.05
Issuance of Preferred Equity	149	0.00	0.00	310	76	126
Issuance of Common Equity	0.00	0.00	-0.39	367	10	0.00
Other Financing Activities, net	-16	-5.90	2.61	35	4.51	1.65
Effect of Exchange Rate Changes	-0.01	-0.03	-0.12	-0.01	0.00	-
Cash Interest Paid	6.15	28	25	6.43	0.00	0.00
Cash Income Taxes Paid	0.08	0.11	0.28	0.88	0.03	0.01

This table details how cash moves in and out of Blend Labs' business through operations, investing, and financing, using quarterly figures. All values are USD millions unless otherwise specified.

Metric	Q1 2025	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022
Period end date	3/31/2025	12/31/2024	9/30/2024	6/30/2024	3/31/2024	12/31/2023	9/30/2023	6/30/2023	3/31/2023	12/31/2022	9/30/2022
Net Change in Cash & Equivalents	18	-13	9.59	-39	54	-54	45	-4.26	-78	9.82	-18
Net Cash From Operating Activities	20	-4.59	2.08	-6.67	-3.87	-21	-26	-34	-47	-47	-50
Net Cash From Continuing Operating Activities	20	-4.59	2.08	-6.67	-3.87	-21	-26	-34	-47	-47	-50
Net Income / (Loss) Continuing Operations	-6.61	-0.71	-2.63	-19	-21	-30	-42	-41	-66	-81	-133
Consolidated Net Income / (Loss)	-9.41	-0.71	-2.63	-19	-21	-30	-42	-41	-66	-81	-133
Net Income / (Loss) Discontinued Operations	-2.80	-	-	-	-	-	-	-	-	-	-
Depreciation Expense	0.41	0.49	0.68	0.56	0.56	0.61	0.60	0.63	0.63	0.61	0.93
Amortization Expense	0.39	0.49	3.88	1.27	1.65	2.09	2.31	2.33	2.52	2.94	2.91
Non-Cash Adjustments To Reconcile Net Income	5.91	5.74	-2.90	13	3.42	9.66	7.76	12	15	28	83
Changes in Operating Assets and Liabilities, net	20	-11	3.04	-1.72	11	-3.22	5.04	-7.42	1.35	2.20	-5.00
Net Cash From Discontinued Operating Activities	0.31	-	-	-	-	-	-	-	-	-	-
Net Cash From Investing Activities	3.23	-1.89	12	-25	61	53	72	31	-29	57	31
Net Cash From Continuing Investing Activities	3.31	-1.89	12	-25	61	53	72	31	-29	57	31
Purchase of Property, Plant & Equipment	-4.59	-2.58	-3.43	-1.87	-1.96	-0.08	-0.03	-0.17	-0.30	-0.46	-0.45
Purchase of Investments	-12	-5.61	-20	-28	-48	-33	-8.32	-8.75	-186	-49	-46
Sale and/or Maturity of Investments	20	11	26	5.00	111	89	80	40	158	107	78
Net Cash From Discontinued Investing Activities	-0.08	-	-	-	-	-	-	-	-	-	-
Net Cash From Financing Activities	-5.18	-6.32	-4.23	-7.32	-3.19	-86	-1.33	-1.09	-2.42	0.04	0.94
Net Cash From Continuing Financing Activities	-5.18	-6.32	-4.23	-7.32	-3.19	-86	-1.33	-1.09	-2.42	0.04	0.94
Repurchase of Common Equity	-2.57	-	-0.40	-	-	-	-	-	-	0.39	-
Other Financing Activities, net	-2.61	-6.32	-3.83	-3.12	-3.19	-1.07	-1.33	-1.09	-2.42	0.04	0.94
Effect of Exchange Rate Changes	0.00	-	-	-0.00	-0.00	-0.02	-0.02	0.01	0.01	-0.28	0.06
Cash Interest Paid	0.00	-	-	1.62	4.53	6.35	7.36	7.19	6.91	6.50	8.89
Cash Income Taxes Paid	0.13	-	-	0.07	0.01	0.06	-	-0.05	0.10	0.09	0.05

This table presents Blend Labs' assets and liabilities at the end of each period, using annual balance sheet data. All values are USD millions unless otherwise specified.

Metric	2024	2023	2022	2021	2020
Period end date	12/31/2024	12/31/2023	12/31/2022	12/31/2021	12/31/2020
Total Assets	178	206	433	1,112	216
Total Current Assets	135	170	396	613	186
Cash & Equivalents	42	31	124	213	41
Short-Term Investments	56	106	230	334	111
Accounts Receivable	17	18	23	34	15
Prepaid Expenses	19	15	19	32	19
Plant, Property, & Equipment, net	12	3.95	5.74	6.16	4.59
Total Noncurrent Assets	31	32	31	493	25
Intangible Assets	2.08	2.11	2.13	173	1.21
Other Noncurrent Operating Assets	28	30	29	33	24
Total Liabilities & Shareholders' Equity	178	206	433	1,112	216
Total Liabilities	40	179	269	302	52
Total Current Liabilities	39	32	35	60	35
Accounts Payable	2.42	2.17	1.26	6.16	3.44
Current Deferred Revenue	19	8.98	8.70	8.07	14
Current Employee Benefit Liabilities	3.98	5.56	10	18	9.06
Other Current Liabilities	13	15	15	28	8.91
Total Noncurrent Liabilities	1.38	148	233	242	17
Long-Term Debt	0.00	138	217	214	0.00
Other Noncurrent Operating Liabilities	1.38	9.21	17	28	17
Commitments & Contingencies	0.00	0.00	0.00	0.00	0.00
Redeemable Noncontrolling Interest	194	46	41	36	0.00
Total Equity & Noncontrolling Interests	-56	-19	123	775	163
Total Preferred & Common Equity	-56	-19	123	775	163
Total Common Equity	-56	-19	123	775	-222
Common Stock	1,328	1,322	1,287	1,218	51
Retained Earnings	-1,385	-1,342	-1,163	-443	-273
Accumulated Other Comprehensive Income / (Loss)	0.60	0.44	-0.71	-0.81	-0.01

This table presents Blend Labs' assets and liabilities at the end of each period, using quarterly balance sheet data. All values are USD millions unless otherwise specified.

Metric	Q1 2025	Q3 2024	Q2 2024	Q1 2024	Q3 2023	Q2 2023	Q1 2023	Q3 2022
Period end date	3/31/2025	9/30/2024	6/30/2024	3/31/2024	9/30/2023	6/30/2023	3/31/2023	9/30/2022
Total Assets	188	186	185	202	318	350	385	493
Total Current Assets	140	146	143	160	283	309	350	454
Cash & Equivalents	56	55	45	85	85	35	46	114
Short-Term Investments	49	62	67	44	160	231	261	286
Accounts Receivable	11	16	20	18	20	21	20	28
Prepaid Expenses	16	14	10	13	19	22	23	25
Other Current Nonoperating Assets	8.52	-	-	-	-	-	-	-
Plant, Property, & Equipment, net	17	9.72	7.62	5.98	4.45	4.97	5.41	6.04
Total Noncurrent Assets	31	30	35	36	31	36	30	33
Intangible Assets	0.08	2.09	2.10	2.10	2.11	2.12	2.12	2.13
Other Noncurrent Operating Assets	25	28	33	34	29	34	28	31
Other Noncurrent Nonoperating Assets	5.84	-	-	-	-	-	-	-
Total Liabilities & Shareholders' Equity	188	186	185	202	318	350	385	493
Total Liabilities	59	47	48	190	267	266	272	278
Total Current Liabilities	58	45	42	43	37	35	40	44
Accounts Payable	2.67	1.86	1.08	1.90	2.12	3.15	1.93	2.55
Current Deferred Revenue	33	20	21	22	10	12	13	9.96
Current Employee Benefit Liabilities	3.90	6.05	3.23	5.19	9.87	4.74	11	14
Other Current Liabilities	11	17	16	14	15	15	14	18
Other Current Nonoperating Liabilities	6.79	-	-	-	-	-	-	-
Total Noncurrent Liabilities	1.19	2.25	6.74	147	230	231	232	234
Other Noncurrent Operating Liabilities	0.29	1.29	1.57	2.06	11	13	15	18
Other Noncurrent Nonoperating Liabilities	0.90	-	-	-	-	-	-	-
Commitments & Contingencies	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Redeemable Noncontrolling Interest	146	188	183	48	45	43	42	39
Total Equity & Noncontrolling Interests	-17	-50	-45	-36	6.29	41	71	176
Total Preferred & Common Equity	-17	-50	-45	-36	6.29	41	71	176
Total Common Equity	-17	-50	-45	-36	6.29	41	71	176
Common Stock	1,377	1,334	1,336	1,326	1,318	1,312	1,300	1,260
Retained Earnings	-1,394	-1,384	-1,382	-1,362	-1,311	-1,270	-1,228	-1,082
Accumulated Other Comprehensive Income / (Loss)	0.57	0.77	0.30	0.35	-0.40	-0.69	0.10	-2.16

This table displays calculated financial ratios and metrics derived from Blend Labs' official financial filings.

Metric	2024	2023	2022	2021	2020	2019
Period end date	12/31/2024	12/31/2023	12/31/2022	12/31/2021	12/31/2020	12/31/2019
Growth Metrics	-	-	-	-	-	-
Revenue Growth	3.30%	-33.31%	0.30%	144.19%	89.51%	0.00%
EBITDA Growth	80.33%	80.91%	-307.42%	-173.26%	13.19%	0.00%
EBIT Growth	75.46%	79.90%	-276.75%	-163.77%	8.41%	0.00%
NOPAT Growth	68.24%	79.06%	-278.31%	-161.97%	7.87%	0.00%
Net Income Growth	75.86%	76.45%	-351.58%	-126.68%	8.39%	0.00%
EPS Growth	68.42%	76.83%	-152.31%	31.22%	24.10%	0.00%
Operating Cash Flow Growth	89.78%	32.98%	-49.34%	-96.12%	-10.31%	0.00%
Free Cash Flow Firm Growth	58.99%	-55.02%	88.13%	-841.36%	0.00%	0.00%
Invested Capital Growth	38.25%	6.71%	-94.43%	4,071.01%	0.00%	0.00%
Revenue Q/Q Growth	3.38%	-4.09%	-13.97%	0.00%	0.00%	0.00%
EBITDA Q/Q Growth	43.71%	26.46%	-2.42%	0.00%	0.00%	0.00%
EBIT Q/Q Growth	38.29%	25.22%	-1.91%	0.00%	0.00%	0.00%
NOPAT Q/Q Growth	28.81%	25.44%	-2.09%	0.00%	0.00%	0.00%
Net Income Q/Q Growth	40.59%	22.11%	-1.32%	0.00%	0.00%	0.00%
EPS Q/Q Growth	27.27%	21.65%	-0.31%	0.00%	0.00%	0.00%
Operating Cash Flow Q/Q Growth	55.25%	17.27%	-2.26%	-33.73%	0.00%	0.00%
Free Cash Flow Firm Q/Q Growth	1.99%	21.47%	0.00%	0.00%	0.00%	0.00%
Invested Capital Q/Q Growth	71.90%	13.03%	-12.08%	0.00%	0.00%	0.00%
Profitability Metrics	-	-	-	-	-	-
Gross Margin	55.88%	51.73%	38.12%	49.46%	64.29%	61.42%
EBITDA Margin	-16.66%	-87.52%	-305.76%	-75.27%	-67.27%	-146.85%
Operating Margin	-30.63%	-99.60%	-317.25%	-84.11%	-78.40%	-161.28%
EBIT Margin	-22.57%	-94.98%	-315.16%	-83.90%	-77.68%	-160.72%
Profit (Net Income) Margin	-26.80%	-114.69%	-324.75%	-72.13%	-77.70%	-160.75%
Tax Burden Percent	100.25%	100.05%	99.71%	81.31%	100.03%	100.02%
Interest Burden Percent	118.45%	120.68%	103.34%	105.73%	100.00%	100.00%
Effective Tax Rate	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Return on Invested Capital (ROIC)	-102.82%	-398.13%	-207.36%	-56.51%	-921.31%	0.00%
ROIC Less NNEP Spread (ROIC-NNEP)	-84.92%	-294.37%	-104.76%	-43.71%	-892.46%	0.00%
Return on Net Nonoperating Assets (RNNOA)	50.07%	209.65%	50.60%	21.78%	829.95%	0.00%
Return on Equity (ROE)	-52.75%	-188.49%	-156.76%	-34.73%	-91.37%	0.00%
Cash Return on Invested Capital (CROIC)	-134.92%	-404.63%	-28.46%	-247.15%	-1,121.31%	0.00%
Operating Return on Assets (OROA)	-19.04%	-46.64%	-95.94%	-29.63%	-34.57%	0.00%
Return on Assets (ROA)	-22.61%	-56.32%	-98.86%	-25.47%	-34.59%	0.00%
Return on Common Equity (ROCE)	24.22%	-102.63%	-144.42%	-19.71%	124.12%	0.00%
Return on Equity Simple (ROE_SIMPLE)	77.04%	934.78%	-620.12%	-21.83%	-45.68%	0.00%
Net Operating Profit after Tax (NOPAT)	-35	-109	-522	-138	-53	-57
NOPAT Margin	-21.44%	-69.72%	-222.08%	-58.88%	-54.88%	-112.90%
Net Nonoperating Expense Percent (NNEP)	-17.90%	-103.76%	-102.60%	-12.81%	-28.85%	0.00%
Return On Investment Capital (ROIC_SIMPLE)	61.63%	-91.83%	-153.64%	-	-	-
Cost of Revenue to Revenue	44.12%	48.27%	61.88%	50.54%	35.71%	38.58%
SG&A Expenses to Revenue	31.20%	45.07%	59.15%	54.93%	31.35%	52.47%
R&D to Revenue	28.45%	52.02%	58.71%	39.33%	57.80%	95.91%
Operating Expenses to Revenue	86.51%	151.33%	355.37%	133.58%	142.70%	222.70%
Earnings before Interest and Taxes (EBIT)	-37	-149	-741	-197	-75	-81
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)	-27	-137	-719	-177	-65	-74
Valuation Ratios	-	-	-	-	-	-
Price to Book Value (P/BV)	0.00	0.00	2.78	2.18	0.00	0.00
Price to Tangible Book Value (P/TBV)	0.00	0.00	2.83	5.37	0.00	0.00
Price to Revenue (P/Rev)	6.65	4.04	1.46	7.20	3.75	7.10
Price to Earnings (P/E)	0.00	0.00	0.00	0.00	0.00	0.00
Dividend Yield	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Earnings Yield	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Enterprise Value to Invested Capital (EV/IC)	29.92	24.00	9.25	2.91	51.86	0.00
Enterprise Value to Revenue (EV/Rev)	7.24	4.34	1.04	5.93	6.18	0.00
Enterprise Value to EBITDA (EV/EBITDA)	0.00	0.00	0.00	0.00	0.00	0.00
Enterprise Value to EBIT (EV/EBIT)	0.00	0.00	0.00	0.00	0.00	0.00
Enterprise Value to NOPAT (EV/NOPAT)	0.00	0.00	0.00	0.00	0.00	0.00
Enterprise Value to Operating Cash Flow (EV/OCF)	0.00	0.00	0.00	0.00	0.00	0.00
Enterprise Value to Free Cash Flow (EV/FCFF)	0.00	0.00	0.00	0.00	0.00	0.00
Leverage & Solvency	-	-	-	-	-	-
Debt to Equity	0.00	5.13	1.32	0.26	0.00	0.00
Long-Term Debt to Equity	0.00	5.13	1.32	0.26	0.00	0.00
Financial Leverage	-0.59	-0.71	-0.48	-0.50	-0.93	0.00
Leverage Ratio	2.33	3.35	1.59	1.36	1.32	0.00
Compound Leverage Factor	2.76	4.04	1.64	1.44	1.32	0.00
Debt to Total Capital	0.00%	83.70%	56.94%	20.87%	0.00%	0.00%
Short-Term Debt to Total Capital	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Long-Term Debt to Total Capital	0.00%	83.70%	56.94%	20.87%	0.00%	0.00%
Preferred Equity to Total Capital	0.00%	0.00%	0.00%	0.00%	235.85%	0.00%
Noncontrolling Interests to Total Capital	140.93%	27.95%	10.70%	3.51%	0.00%	0.00%
Common Equity to Total Capital	-40.93%	-11.64%	32.35%	75.62%	-135.85%	0.00%
Debt to EBITDA	0.00	-1.01	-0.30	-1.21	0.00	0.00
Net Debt to EBITDA	0.00	-0.01	0.19	1.89	0.00	0.00
Long-Term Debt to EBITDA	0.00	-1.01	-0.30	-1.21	0.00	0.00
Debt to NOPAT	0.00	-1.27	-0.42	-1.55	0.00	0.00
Net Debt to NOPAT	0.00	-0.01	0.26	2.41	0.00	0.00
Long-Term Debt to NOPAT	0.00	-1.27	-0.42	-1.55	0.00	0.00
Altman Z-Score	6.02	-7.81	-7.11	3.02	2.50	0.00
Noncontrolling Interest Sharing Ratio	145.92%	45.55%	7.87%	43.24%	235.85%	0.00%
Liquidity Ratios	-	-	-	-	-	-
Current Ratio	3.47	5.38	11.17	10.21	5.31	0.00
Quick Ratio	2.97	4.92	10.62	9.68	4.76	0.00
Cash Flow Metrics	-	-	-	-	-	-
Free Cash Flow to Firm (FCFF)	-46	-111	-72	-604	-64	0.00
Operating Cash Flow to CapEx	-132.51%	-21,741.23%	-9,207.83%	-6,760.55%	-4,917.78%	-10,161.90%
Free Cash Flow to Firm to Interest Expense	-6.76	-3.61	-2.89	-53.54	0.00	0.00
Operating Cash Flow to Interest Expense	-1.93	-4.14	-7.68	-11.30	0.00	0.00
Operating Cash Flow Less CapEx to Interest Expense	-3.39	-4.16	-7.76	-11.47	0.00	0.00
Efficiency Ratios	-	-	-	-	-	-
Asset Turnover	0.84	0.49	0.30	0.35	0.45	0.00
Accounts Receivable Turnover	9.07	7.64	8.28	9.56	6.41	0.00
Inventory Turnover	0.00	0.00	0.00	0.00	0.00	0.00
Fixed Asset Turnover	19.92	32.38	39.54	43.63	20.90	0.00
Accounts Payable Turnover	31.16	44.15	39.23	24.70	9.98	0.00
Days Sales Outstanding (DSO)	40.22	47.78	44.07	38.18	56.94	0.00
Days Inventory Outstanding (DIO)	0.00	0.00	0.00	0.00	0.00	0.00
Days Payable Outstanding (DPO)	11.71	8.27	9.30	14.78	36.59	0.00
Cash Conversion Cycle (CCC)	28.51	39.51	34.76	23.40	20.36	0.00
Capital & Investment Metrics	-	-	-	-	-	-
Invested Capital	39	28	27	477	11	0.00
Invested Capital Turnover	4.80	5.71	0.93	0.96	16.79	0.00
Increase / (Decrease) in Invested Capital	11	1.78	-451	466	11	0.00
Enterprise Value (EV)	1,173	681	246	1,390	593	0.00
Market Capitalization	1,077	633	342	1,688	360	360
Book Value per Share	($0.22)	($0.08)	$0.52	$3.37	($5.63)	$0.00
Tangible Book Value per Share	($0.23)	($0.09)	$0.51	$1.37	($5.66)	$0.00
Total Capital	138	165	381	1,024	163	0.00
Total Debt	0.00	138	217	214	0.00	0.00
Total Long-Term Debt	0.00	138	217	214	0.00	0.00
Net Debt	-98	1.41	-137	-333	-152	0.00
Capital Expenditures (CapEx)	9.84	0.59	2.07	1.89	1.32	0.58
Debt-free, Cash-free Net Working Capital (DFCFNWC)	-2.26	1.34	6.48	5.76	-0.78	0.00
Debt-free Net Working Capital (DFNWC)	96	138	361	553	151	0.00
Net Working Capital (NWC)	96	138	361	553	151	0.00
Net Nonoperating Expense (NNE)	8.69	71	241	31	22	24
Net Nonoperating Obligations (NNO)	-98	1.41	-137	-333	-152	0.00
Total Depreciation and Amortization (D&A)	9.57	12	22	20	10.00	7.03
Debt-free, Cash-free Net Working Capital to Revenue	-1.39%	0.85%	2.75%	2.46%	-0.81%	0.00%
Debt-free Net Working Capital to Revenue	59.39%	88.15%	153.33%	235.82%	157.37%	0.00%
Net Working Capital to Revenue	59.39%	88.15%	153.33%	235.82%	157.37%	0.00%
Earnings Adjustments	-	-	-	-	-	-
Adjusted Basic Earnings per Share	($0.24)	($0.76)	($3.28)	($1.30)	$0.00	$0.00
Adjusted Weighted Average Basic Shares Outstanding	253.92M	245.21M	234.16M	131.99M	0.00	0.00
Adjusted Diluted Earnings per Share	($0.24)	($0.76)	($3.28)	($1.30)	$0.00	$0.00
Adjusted Weighted Average Diluted Shares Outstanding	253.92M	245.21M	234.16M	131.99M	0.00	0.00
Adjusted Basic & Diluted Earnings per Share	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding	259.66M	252.05M	242.85M	232.41M	0.00	0.00
Normalized Net Operating Profit after Tax (NOPAT)	-30	-92	-197	-138	-53	-57
Normalized NOPAT Margin	-18.21%	-58.59%	-83.70%	-58.88%	-54.88%	-112.90%
Pre Tax Income Margin	-26.73%	-114.63%	-325.70%	-88.71%	-77.68%	-160.72%
Debt Service Ratios	-	-	-	-	-	-
EBIT to Interest Expense	-5.42	-4.84	-29.90	-17.44	0.00	0.00
NOPAT to Interest Expense	-5.15	-3.55	-21.07	-12.24	0.00	0.00
EBIT Less CapEx to Interest Expense	-6.88	-4.85	-29.99	-17.61	0.00	0.00
NOPAT Less CapEx to Interest Expense	-6.61	-3.57	-21.15	-12.41	0.00	0.00
Payout Ratios	-	-	-	-	-	-
Dividend Payout Ratio	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Augmented Payout Ratio	-21.83%	0.00%	0.00%	0.00%	0.00%	-0.06%

This table displays calculated financial ratios and metrics derived from Blend Labs' official financial filings.

Metric	Q1 2025	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022
Period end date	3/31/2025	12/31/2024	9/30/2024	6/30/2024	3/31/2024	12/31/2023	9/30/2023	6/30/2023	3/31/2023	12/31/2022	9/30/2022
Growth Metrics	-	-	-	-	-	-	-	-	-	-	-
Revenue Growth	12.29%	14.69%	11.32%	-5.45%	-6.40%	-15.62%	-26.67%	-34.67%	-47.80%	-47.17%	-38.20%
EBITDA Growth	57.90%	101.40%	106.38%	47.84%	75.97%	70.50%	75.02%	93.42%	11.09%	-32.01%	-97.15%
EBIT Growth	57.74%	97.08%	92.23%	47.00%	73.49%	68.26%	73.48%	92.90%	15.94%	-23.20%	-79.76%
NOPAT Growth	63.75%	91.83%	63.21%	63.67%	65.53%	70.90%	72.12%	92.21%	11.92%	-25.54%	-84.10%
Net Income Growth	54.45%	97.67%	93.72%	53.19%	68.78%	62.70%	68.50%	91.31%	8.59%	-13.89%	-73.91%
EPS Growth	0.00%	75.00%	83.33%	50.00%	67.86%	63.64%	68.42%	91.26%	12.50%	-3.13%	-50.00%
Operating Cash Flow Growth	627.15%	77.84%	108.02%	80.62%	91.71%	56.29%	48.72%	26.45%	-1.77%	-9.76%	-61.40%
Free Cash Flow Firm Growth	131.25%	29.21%	65.15%	-109.26%	-104.83%	-104.29%	-105.41%	113.96%	178.06%	0.00%	168.67%
Invested Capital Growth	-39.90%	38.25%	-9.10%	-20.28%	21.22%	6.71%	-16.99%	-54.65%	-94.99%	-94.43%	-93.89%
Revenue Q/Q Growth	-35.35%	-8.36%	11.62%	15.83%	-3.20%	-11.05%	-5.19%	14.67%	-12.74%	-22.71%	-15.54%
EBITDA Q/Q Growth	-2,100.00%	-85.22%	112.27%	-19.65%	35.60%	32.58%	-0.41%	44.89%	20.93%	42.91%	73.55%
EBIT Q/Q Growth	-864.66%	73.86%	85.30%	-14.35%	33.57%	30.39%	-0.23%	42.81%	20.46%	41.84%	73.15%
NOPAT Q/Q Growth	-330.50%	86.58%	0.15%	37.01%	3.16%	39.59%	1.42%	40.23%	18.26%	42.12%	72.45%
Net Income Q/Q Growth	-1,229.38%	73.05%	86.47%	6.01%	31.98%	27.36%	-0.80%	37.32%	18.72%	38.65%	72.18%
EPS Q/Q Growth	0.00%	0.00%	66.67%	0.00%	25.00%	33.33%	0.00%	35.71%	15.15%	42.11%	72.33%
Operating Cash Flow Q/Q Growth	544.61%	-320.91%	131.14%	-72.34%	81.31%	20.07%	24.73%	26.29%	1.44%	6.24%	-7.97%
Free Cash Flow Firm Q/Q Growth	151.54%	-71.81%	-295.96%	91.07%	17.25%	15.40%	-205.20%	-95.34%	3.56%	6.50%	371.68%
Invested Capital Q/Q Growth	-55.36%	71.90%	-23.24%	2.03%	-17.60%	13.03%	-32.68%	55.15%	-9.60%	-12.08%	-63.22%
Profitability Metrics	-	-	-	-	-	-	-	-	-	-	-
Gross Margin	70.82%	59.72%	57.53%	53.55%	51.91%	54.64%	54.35%	54.87%	42.46%	33.67%	38.14%
EBITDA Margin	-21.59%	0.70%	4.33%	-39.35%	-38.09%	-57.25%	-75.53%	-71.32%	-148.39%	-163.77%	-221.74%
Operating Margin	-28.74%	-4.32%	-29.48%	-32.95%	-60.59%	-60.57%	-89.18%	-85.77%	-164.55%	-175.66%	-234.60%
EBIT Margin	-24.58%	-1.65%	-5.77%	-43.85%	-44.42%	-64.72%	-82.69%	-78.22%	-156.83%	-172.07%	-228.67%
Profit (Net Income) Margin	-35.16%	-1.71%	-5.81%	-47.98%	-59.13%	-84.13%	-103.03%	-96.90%	-177.29%	-190.35%	-239.82%
Tax Burden Percent	143.06%	103.81%	100.69%	100.12%	100.20%	99.76%	100.11%	100.13%	100.11%	100.59%	100.01%
Interest Burden Percent	100.00%	100.00%	100.00%	109.28%	132.85%	130.32%	124.46%	123.73%	112.93%	109.98%	104.87%
Effective Tax Rate	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Return on Invested Capital (ROIC)	-142.35%	-14.49%	-135.02%	-104.77%	-246.55%	-242.10%	-369.08%	-179.22%	-92.02%	-114.82%	-171.02%
ROIC Less NNEP Spread (ROIC-NNEP)	-133.80%	-15.61%	-144.47%	-91.74%	-230.35%	-219.93%	-353.44%	-168.05%	-79.63%	-102.57%	-156.21%
Return on Net Nonoperating Assets (RNNOA)	89.52%	9.20%	107.99%	64.03%	132.63%	156.63%	279.97%	118.12%	33.96%	49.54%	80.98%
Return on Equity (ROE)	-52.83%	-5.29%	-27.03%	-40.74%	-113.92%	-85.47%	-89.11%	-61.10%	-58.06%	-65.27%	-90.04%
Cash Return on Invested Capital (CROIC)	-58.53%	-134.92%	-194.20%	-170.93%	-324.67%	-404.63%	-511.69%	-280.13%	-24.38%	-28.46%	0.00%
Operating Return on Assets (OROA)	-20.79%	-1.39%	-3.59%	-24.89%	-23.37%	-31.78%	-33.34%	-29.36%	-43.79%	-52.38%	-74.83%
Return on Assets (ROA)	-29.74%	-1.44%	-3.61%	-27.24%	-31.11%	-41.31%	-41.54%	-36.38%	-49.50%	-57.95%	-78.48%
Return on Common Equity (ROCE)	19.74%	2.43%	6.17%	0.77%	-32.36%	-46.54%	-60.90%	-48.69%	-52.83%	-60.14%	-82.94%
Return on Equity Simple (ROE_SIMPLE)	190.50%	0.00%	147.35%	246.93%	375.66%	0.00%	-3,670.47%	-779.98%	-1,061.85%	0.00%	-429.40%
Net Operating Profit after Tax (NOPAT)	-5.39	-1.25	-9.32	-9.34	-15	-15	-25	-26	-43	-53	-91
NOPAT Margin	-20.12%	-3.02%	-20.63%	-23.07%	-42.41%	-42.40%	-62.42%	-60.04%	-115.18%	-122.96%	-164.22%
Net Nonoperating Expense Percent (NNEP)	-8.55%	1.12%	9.45%	-13.03%	-16.20%	-22.17%	-15.64%	-11.17%	-12.39%	-12.25%	-14.81%
Return On Investment Capital (ROIC_SIMPLE)	31.89%	2.22%	-	-	-	-12.85%	-	-	-	-15.47%	-
Cost of Revenue to Revenue	29.18%	40.28%	42.47%	46.45%	48.09%	45.36%	45.65%	45.13%	57.54%	66.33%	61.86%
SG&A Expenses to Revenue	41.93%	26.46%	29.08%	30.94%	39.87%	40.28%	38.97%	45.89%	55.39%	78.08%	58.06%
R&D to Revenue	28.09%	21.40%	22.41%	31.91%	40.58%	39.93%	46.38%	51.60%	70.33%	77.71%	61.86%
Operating Expenses to Revenue	99.56%	64.04%	87.01%	86.50%	112.50%	115.20%	143.53%	140.64%	207.01%	209.34%	272.73%
Earnings before Interest and Taxes (EBIT)	-6.58	-0.68	-2.61	-18	-16	-23	-34	-33	-59	-74	-127
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)	-5.78	0.29	1.96	-16	-13	-21	-31	-31	-55	-70	-123
Valuation Ratios	-	-	-	-	-	-	-	-	-	-	-
Price to Book Value (P/BV)	0.00	0.00	0.00	0.00	0.00	0.00	53.54	5.60	3.39	2.78	2.96
Price to Tangible Book Value (P/TBV)	0.00	0.00	0.00	0.00	0.00	0.00	80.63	5.90	3.49	2.83	2.99
Price to Revenue (P/Rev)	5.27	6.65	6.08	3.92	5.30	4.04	2.06	1.30	1.20	1.46	1.90
Price to Earnings (P/E)	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Dividend Yield	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Earnings Yield	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Enterprise Value to Invested Capital (EV/IC)	52.05	29.92	44.98	22.58	30.36	24.00	14.18	6.09	8.10	9.25	12.37
Enterprise Value to Revenue (EV/Rev)	5.52	7.24	6.55	4.41	5.72	4.34	2.17	1.27	0.97	1.04	1.37
Enterprise Value to EBITDA (EV/EBITDA)	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Enterprise Value to EBIT (EV/EBIT)	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Enterprise Value to NOPAT (EV/NOPAT)	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Enterprise Value to Operating Cash Flow (EV/OCF)	81.23	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Enterprise Value to Free Cash Flow (EV/FCFF)	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Leverage & Solvency	-	-	-	-	-	-	-	-	-	-	-
Debt to Equity	0.00	0.00	0.01	0.04	12.21	5.13	4.29	2.58	1.92	1.32	1.00
Long-Term Debt to Equity	0.00	0.00	0.01	0.04	12.21	5.13	4.29	2.58	1.92	1.32	1.00
Financial Leverage	-0.67	-0.59	-0.75	-0.70	-0.58	-0.71	-0.79	-0.70	-0.43	-0.48	-0.52
Leverage Ratio	2.77	2.33	2.66	2.42	4.69	3.35	3.05	2.36	1.64	1.59	1.53
Compound Leverage Factor	2.77	2.33	2.66	2.64	6.23	4.36	3.79	2.92	1.85	1.74	1.61
Debt to Total Capital	0.00%	0.00%	0.68%	3.63%	92.43%	83.70%	81.10%	72.06%	65.74%	56.94%	50.11%
Short-Term Debt to Total Capital	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Long-Term Debt to Total Capital	0.00%	0.00%	0.68%	3.63%	92.43%	83.70%	81.10%	72.06%	65.74%	56.94%	50.11%
Preferred Equity to Total Capital	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Noncontrolling Interests to Total Capital	113.09%	140.93%	134.85%	128.32%	30.33%	27.95%	16.57%	14.32%	12.70%	10.70%	9.16%
Common Equity to Total Capital	-13.09%	-40.93%	-35.53%	-31.95%	-22.76%	-11.64%	2.33%	13.63%	21.56%	32.35%	40.73%
Debt to EBITDA	0.00	0.00	-0.02	-0.06	-1.53	-1.01	-1.17	-0.78	-0.31	-0.30	-0.31
Net Debt to EBITDA	0.00	0.00	2.42	1.33	-0.18	-0.01	0.14	0.17	0.13	0.19	0.26
Long-Term Debt to EBITDA	0.00	0.00	-0.02	-0.06	-1.53	-1.01	-1.17	-0.78	-0.31	-0.30	-0.31
Debt to NOPAT	0.00	0.00	-0.02	-0.08	-1.79	-1.27	-1.49	-1.03	-0.42	-0.42	-0.42
Net Debt to NOPAT	0.00	0.00	2.37	1.66	-0.21	-0.01	0.18	0.22	0.17	0.26	0.36
Long-Term Debt to NOPAT	0.00	0.00	-0.02	-0.08	-1.79	-1.27	-1.49	-1.03	-0.42	-0.42	-0.42
Altman Z-Score	-0.28	6.68	3.08	-1.87	-5.66	-5.80	-3.92	-3.42	-2.94	-2.02	-1.25
Noncontrolling Interest Sharing Ratio	137.37%	145.92%	122.83%	101.90%	71.59%	45.55%	31.66%	20.30%	9.02%	7.87%	7.89%
Liquidity Ratios	-	-	-	-	-	-	-	-	-	-	-
Current Ratio	2.41	3.47	3.24	3.43	3.75	5.38	7.69	8.87	8.77	11.17	10.29
Quick Ratio	1.99	2.97	2.93	3.18	3.44	4.92	7.19	8.23	8.19	10.62	9.71
Cash Flow Metrics	-	-	-	-	-	-	-	-	-	-	-
Free Cash Flow to Firm (FCFF)	6.23	-12	-7.04	-1.78	-20	-17	-20	19	412	398	374
Operating Cash Flow to CapEx	444.52%	-177.68%	60.49%	-357.04%	-196.95%	-25,232.93%	-83,506.45%	-20,229.41%	-15,346.38%	-10,334.72%	-11,319.51%
Free Cash Flow to Firm to Interest Expense	0.00	0.00	0.00	-1.08	-3.91	-2.41	-2.46	2.42	54.46	54.17	60.69
Operating Cash Flow to Interest Expense	0.00	0.00	0.00	-4.04	-0.76	-2.92	-3.15	-4.33	-6.16	-6.44	-8.20
Operating Cash Flow Less CapEx to Interest Expense	0.00	0.00	0.00	-5.18	-1.14	-2.93	-3.16	-4.35	-6.20	-6.50	-8.27
Efficiency Ratios	-	-	-	-	-	-	-	-	-	-	-
Asset Turnover	0.85	0.84	0.62	0.57	0.53	0.49	0.40	0.38	0.28	0.30	0.33
Accounts Receivable Turnover	11.43	9.07	8.83	7.43	8.11	7.64	6.94	6.83	7.51	8.28	9.36
Inventory Turnover	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Fixed Asset Turnover	14.36	19.92	22.11	24.17	27.12	32.38	31.18	31.80	35.57	39.54	37.84
Accounts Payable Turnover	31.33	31.16	35.73	33.32	37.09	44.15	37.56	32.07	61.45	39.23	34.88
Days Sales Outstanding (DSO)	31.94	40.22	41.31	49.13	44.99	47.78	52.59	53.43	48.59	44.07	39.00
Days Inventory Outstanding (DIO)	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Days Payable Outstanding (DPO)	11.65	11.71	10.22	10.96	9.84	8.27	9.72	11.38	5.94	9.30	10.46
Cash Conversion Cycle (CCC)	20.29	28.51	31.10	38.17	35.15	39.51	42.87	42.04	42.65	34.76	28.53
Capital & Investment Metrics	-	-	-	-	-	-	-	-	-	-	-
Invested Capital	18	39	23	30	29	28	25	37	24	27	30
Invested Capital Turnover	7.08	4.80	6.54	4.54	5.81	5.71	5.91	2.99	0.80	0.93	1.04
Increase / (Decrease) in Invested Capital	-12	11	-2.28	-7.56	5.10	1.78	-5.14	-45	-455	-451	-465
Enterprise Value (EV)	911	1,173	1,026	671	884	681	356	227	195	246	374
Market Capitalization	870	1,077	953	596	819	633	337	231	242	342	519
Book Value per Share	($0.07)	($0.22)	($0.20)	($0.18)	($0.14)	($0.08)	$0.03	$0.17	$0.29	$0.52	$0.75
Tangible Book Value per Share	($0.07)	($0.23)	($0.20)	($0.19)	($0.15)	($0.09)	$0.02	$0.16	$0.29	$0.51	$0.74
Total Capital	129	138	140	142	157	165	270	303	331	381	431
Total Debt	0.00	0.00	0.96	5.17	145	138	219	218	218	217	216
Total Long-Term Debt	0.00	0.00	0.96	5.17	145	138	219	218	218	217	216
Net Debt	-105	-98	-116	-107	17	1.41	-26	-47	-89	-137	-185
Capital Expenditures (CapEx)	4.59	2.58	3.43	1.87	1.96	0.08	0.03	0.17	0.30	0.46	0.45
Debt-free, Cash-free Net Working Capital (DFCFNWC)	-23	-2.26	-16	-12	-11	1.34	1.42	8.90	3.38	6.48	8.89
Debt-free Net Working Capital (DFNWC)	82	96	101	101	117	138	246	274	310	361	410
Net Working Capital (NWC)	82	96	101	101	117	138	246	274	310	361	410
Net Nonoperating Expense (NNE)	4.03	-0.54	-6.70	10	5.84	15	16	16	23	29	42
Net Nonoperating Obligations (NNO)	-111	-98	-116	-107	17	1.41	-26	-47	-89	-137	-185
Total Depreciation and Amortization (D&A)	0.80	0.97	4.56	1.82	2.21	2.70	2.91	2.96	3.15	3.55	3.83
Debt-free, Cash-free Net Working Capital to Revenue	-13.92%	-1.39%	-9.97%	-7.63%	-7.16%	0.85%	0.87%	4.99%	1.68%	2.75%	3.25%
Debt-free Net Working Capital to Revenue	49.62%	59.39%	64.55%	66.39%	75.73%	88.15%	150.66%	153.96%	154.34%	153.33%	149.84%
Net Working Capital to Revenue	49.62%	59.39%	64.55%	66.39%	75.73%	88.15%	150.66%	153.96%	154.34%	153.33%	149.84%
Earnings Adjustments	-	-	-	-	-	-	-	-	-	-	-
Adjusted Basic Earnings per Share	$0.00	($0.03)	($0.03)	($0.09)	($0.09)	($0.12)	($0.18)	($0.18)	($0.28)	($0.33)	($0.57)
Adjusted Weighted Average Basic Shares Outstanding	258.83M	253.92M	254.91M	253.07M	250.93M	245.21M	246.41M	244.26M	241.44M	234.16M	235.27M
Adjusted Diluted Earnings per Share	$0.00	($0.03)	($0.03)	($0.09)	($0.09)	($0.12)	($0.18)	($0.18)	($0.28)	($0.33)	($0.57)
Adjusted Weighted Average Diluted Shares Outstanding	258.83M	253.92M	254.91M	253.07M	250.93M	245.21M	246.41M	244.26M	241.44M	234.16M	235.27M
Adjusted Basic & Diluted Earnings per Share	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding	258.52M	259.66M	255.93M	254.24M	252.38M	252.05M	248.20M	245.89M	243.85M	242.85M	237.70M
Normalized Net Operating Profit after Tax (NOPAT)	-4.88	-1.17	-5.01	-9.19	-14	-15	-19	-24	-34	-51	-46
Normalized NOPAT Margin	-18.24%	-2.82%	-11.08%	-22.71%	-40.45%	-41.05%	-46.69%	-56.20%	-91.22%	-118.12%	-83.54%
Pre Tax Income Margin	-24.58%	-1.65%	-5.77%	-47.92%	-59.01%	-84.34%	-102.92%	-96.78%	-177.10%	-189.24%	-239.79%
Debt Service Ratios	-	-	-	-	-	-	-	-	-	-	-
EBIT to Interest Expense	0.00	0.00	0.00	-10.77	-3.04	-3.30	-4.09	-4.21	-7.74	-10.02	-20.55
NOPAT to Interest Expense	0.00	0.00	0.00	-5.67	-2.91	-2.16	-3.09	-3.23	-5.68	-7.16	-14.76
EBIT Less CapEx to Interest Expense	0.00	0.00	0.00	-11.90	-3.43	-3.31	-4.09	-4.24	-7.78	-10.08	-20.63
NOPAT Less CapEx to Interest Expense	0.00	0.00	0.00	-6.80	-3.29	-2.17	-3.09	-3.26	-5.72	-7.22	-14.83
Payout Ratios	-	-	-	-	-	-	-	-	-	-	-
Dividend Payout Ratio	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Augmented Payout Ratio	-37.45%	-21.83%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%

Frequently Asked Questions About Blend Labs' Financials

When does Blend Labs's fiscal year end?

According to the most recent income statement we have on file, Blend Labs' financial year ends in December. Their financial year 2024 ended on December 31, 2024.

How has Blend Labs' net income changed over the last 5 years?

Blend Labs' net income appears to be on an upward trend, with a most recent value of -$43.42 million in 2024, falling from -$81.45 million in 2019. The previous period was -$179.88 million in 2023. View Blend Labs' forecast to see where analysts expect Blend Labs to go next.

What is Blend Labs's operating income?

Blend Labs's total operating income in 2024 was -$49.62 million, based on the following breakdown:

Total Gross Profit: $90.54 million
Total Operating Expenses: $140.16 million

How has Blend Labs revenue changed over the last 5 years?

Over the last 5 years, Blend Labs' total revenue changed from $50.67 million in 2019 to $162.02 million in 2024, a change of 219.7%.

How much debt does Blend Labs have?

Blend Labs' total liabilities were at $40.33 million at the end of 2024, a 77.5% decrease from 2023, and a 23.0% decrease since 2020.

How much cash does Blend Labs have?

In the past 4 years, Blend Labs' cash and equivalents has ranged from $30.96 million in 2023 to $213.08 million in 2021, and is currently $42.24 million as of their latest financial filing in 2024.

How has Blend Labs' book value per share changed over the last 5 years?

Over the last 5 years, Blend Labs' book value per share changed from 0.00 in 2019 to -0.22 in 2024, a change of -22.0%.

Related Companies

This page (NYSE:BLND) was last updated on 5/25/2025 by MarketBeat.com Staff

From Our Partners

Get 30 Days of MarketBeat All Access for Free

Start Your 30-Day Trial

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Blend Labs (BLND) Financials

Frequently Asked Questions About Blend Labs' Financials

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

Blend Labs (BLND) Financials

Annual Income Statements for Blend Labs

Quarterly Income Statements for Blend Labs

Annual Cash Flow Statements for Blend Labs

Quarterly Cash Flow Statements for Blend Labs

Annual Balance Sheets for Blend Labs

Quarterly Balance Sheets for Blend Labs

Annual Metrics And Ratios for Blend Labs

Quarterly Metrics And Ratios for Blend Labs

Frequently Asked Questions About Blend Labs' Financials

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools